Treatment of hydatidiform mole suspected to COVID 19
Fatemeh Azarkish1, Saeedeh Rigiyousefabadi1, Roksana Janghorban2, Mohammadmehran Aminifard3, Shirin Bozorgzadeh4, Mahya Zahirnia5, Mansooreh Sadat Golmohammadi4, Elahe Mirtalaie6, Arezoo Pirak7, Zahra Atarodi Kashani7
1 Tropical and Communicable Diseases Research Center, Iranshahr University of Medical Sciences; Department of Midwifery, Iranshahr University of Medical Sciences, Iranshahr, Iran 2 Department of Midwifery, School of Nursing and Midwifery, Maternal – Fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran 3 Department of Surgery, Iranshahr University of Medical Sciences, Iranshahr, Iran 4 Department of Obstetrics and Gynecology, Iranshahr University of Medical Sciences, Iranshahr, Iran 5 Department of Infectious Diseases, Iranshahr University of Medical Sciences, Iranshahr, Iran 6 Department of Internal Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran 7 Department of Midwifery, Iranshahr University of Medical Sciences, Iranshahr, Iran
Correspondence Address:
Dr. Saeedeh Rigiyousefabadi Tropical and Communicable Diseases Research Center, Department of Midwifery, Iranshahr University of Medical Sciences, Iranshahr Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/abr.abr_142_21
|
The aim of this study was to report a case of the treatment of hydatidiform mole in Coronavirus pandemic in Iranshahr. A 17-year-old primiparous woman with gestational age of 14 weeks presented with unilateral leg swelling and sudden abdominal distension beginning in the night before referring to the health center. In the abdominal examination of the patient by a healthcare provider, the baby's heartbeat was not heard and a mismatch was observed between gestational age and fundal height, which corresponded to approximately 24 weeks of gestation. She was conscious and pale with hematuria and uterine contractions. After inserting two IV lines, the patient immediately underwent monitoring and was visited by a gynecologist. Complete molar pregnancy was diagnosed with an enlarged heterogeneous uterus 180 cm × 90 cm in size and containing 170 mm × 80 mm cysts. The treatment began with vancomycin AMP, hydrocortisone AMP, oseltamivir CAP 75 mg, kaletra CAP 200 mg, and meropenem AMP.
|